DrugPatentWatch Database Preview
Drugs in Development Information for Antipyrine
» See Plans and Pricing
What is the development status for investigational drug Antipyrine?
Antipyrine is an investigational drug.
There have been 5 clinical trials for Antipyrine.
The most recent clinical trial was a Phase 3 trial, which was initiated on November 1st 2011.
The most common disease conditions in clinical trials are Gonadal Dysgenesis, Otitis Media, and HIV Infections. The leading clinical trial sponsors are Merck Sharp & Dohme Corp., Global United Pharmaceutical Corporation, and Pernix Theraputics LLC.
There are two US patents protecting this investigational drug and twenty-eight international patents.
Summary for Antipyrine
| US Patents | 2,554 |
| International Patents | 28,250 |
| US Patent Applications | 3,441 |
| WIPO Patent Applications | 1,600 |
| Japanese Patent Applications | 10 |
| Clinical Trial Progress | Phase 3 (2011-11-01) |
| Vendors | 77 |
Recent Clinical Trials for Antipyrine
| Title | Sponsor | Phase |
|---|---|---|
| Assessing the Efficacy of CREWS01 to Decrease Usage of Rescue Inhalers in Moderate to Severe Asthmatic Adults | Global United Pharmaceutical Corporation | Phase 2 |
| Four Arm Safety & Efficacy With Antipyrine and Benzocaine Otic Solution in Children With Acute Otitis Media | Pernix Theraputics LLC | Phase 2 |
| Study to Assess the Safety and Efficacy of Etoricoxib Versus Ibuprofen in the Treatment of Dysmenorrhea (MK-0663-145 AM1) | Merck Sharp & Dohme Corp. | Phase 3 |
Clinical Trial Summary for Antipyrine
Top disease conditions for Antipyrine
Top clinical trial sponsors for Antipyrine
US Patents for Antipyrine
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| Antipyrine | Start Trial | Pyrazole P38 map kinase inhibitors | Respivert Limited (Buckinghamshire, GB) | Start Trial |
| Antipyrine | Start Trial | Polymer electrolyte membrane, membrane-electrode assembly comprising the same and fuel cell comprising the same | KOLON INDUSTRIES, INC. (Gwacheon-si, KR) | Start Trial |
| Antipyrine | Start Trial | 2,3-dihydrobenzofuran-5YL compounds as DYRK kinase inhibitors | 4SC AG (Planegg-Martinsried, DE) | Start Trial |
| Antipyrine | Start Trial | Fast dissolving solid detergent | Ecolab USA Inc. (St. Paul, MN) | Start Trial |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for Antipyrine
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| Antipyrine | European Patent Office | EP2556065 | 2030-04-01 | Start Trial |
| Antipyrine | Spain | ES2532764 | 2030-04-01 | Start Trial |
| Antipyrine | United Kingdom | GB201005589 | 2030-04-01 | Start Trial |
| Antipyrine | Japan | JP2013523710 | 2030-04-01 | Start Trial |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
